Zacks Investment Research
03 Aug 2026, 09:01 UTC · 6w ago
Verdict
Headline takes no side. We score SAM −1.00 across five claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Zacks has assigned Boston Beer Co. (SAM) a #5 'Strong Sell' rank.
More negative than 92% of claims this week
Boston Beer expects tariff costs to increase to $20-$30 million in 2026, up from approximately $11 million in 2025.
So whatDirectly increasing operating expenses will compress profit margins and reduce net income.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More negative than 81% of claims this week
Analyst estimates project negative revenue growth for Boston Beer through 2027.
So whatLong-term revenue decline suggests a lack of growth catalysts and a shrinking market share.
More negative than 81% of claims this week
GLP-1 weight loss drugs from Novo Nordisk and Eli Lilly are reducing alcohol consumption by altering brain reward pathways.
More negative than 73% of claims this week
Key Boston Beer brands, including Twisted Tea and Truly, are experiencing losses in volume and market share.
More negative than 73% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is rated as a Strong Sell due to unfavorable alcohol consumption trends, falling earnings, and increasing tariff costs.
More positive than 68% of ticker scores this week
The article notes the 'explosion' of its weight loss drugs, which are actively reducing demand for alcohol products.
More positive than 68% of ticker scores this week
The article notes the 'explosion' of its weight loss drugs, which are actively reducing demand for alcohol products.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Globe News Wire
1d ago
More positive than 3% of relationship scores this week
[mutual] Consumption of Eli Lilly's GLP-1 drugs is cited as a factor reducing demand for Boston Beer's alcohol products.
More positive than 3% of relationship scores this week
[mutual] Consumption of Novo Nordisk's GLP-1 drugs is cited as a factor reducing demand for Boston Beer's alcohol products.
−5.5%
Price agrees with the score
$173.17 vs $183.20 close before publication (Jul 31) · not market-adjusted
SAM chart →
